These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18680683)

  • 1. [Introduction: adalimumab in the treatment of psoriasis].
    Ferrándiz C; García-Díez A
    Actas Dermosifiliogr; 2008 Feb; 99 Suppl 3():1-2. PubMed ID: 18680683
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of adalimumab].
    Casado M
    Actas Dermosifiliogr; 2008 Feb; 99 Suppl 3():10-4. PubMed ID: 18680685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recalcitrant pustular psoriasis successfully treated with adalimumab.
    Alvarez AC; Rodríguez-Nevado I; De Argila D; Rubio FP; Rovira I; Torrelo A; Zambrano A
    Pediatr Dermatol; 2011; 28(2):195-7. PubMed ID: 21504452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
    Nijsten T; Spuls PI
    Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
    [No Abstract]   [Full Text] [Related]  

  • 5. Adalimumab vs. etanercept in psoriasis.
    Downs AM
    Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful response to narrow-band UVB in a patient undergoing concomitant treatment with adalimumab for psoriasis.
    Lucas A; Belinchón I; Pérez-Crespo M; Mataix J; Betlloch I
    Australas J Dermatol; 2008 Aug; 49(3):173-4. PubMed ID: 18638229
    [No Abstract]   [Full Text] [Related]  

  • 7. Pregnancy during adalimumab use for psoriasis.
    Dessinioti C; Stefanaki I; Stratigos AJ; Kostaki M; Katsambas A; Antoniou C
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):738-9. PubMed ID: 20569288
    [No Abstract]   [Full Text] [Related]  

  • 8. Psoriasis and its treatment with adalimumab.
    Iaconi A; Feldman SR; Balkrishnan R
    Expert Opin Biol Ther; 2010 Jan; 10(1):133-52. PubMed ID: 20078231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superimposed linear psoriasis unmasked by therapy with adalimumab.
    Arnold AW; Happle R; Itin PH
    Eur J Dermatol; 2010; 20(5):573-4. PubMed ID: 20621851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
    Ryan C; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of psoriasis with adalimumab.
    Pitarch G; Sanchez-Carazo JL; Mahiques L; Perez-Ferriols MA; Fortea JM
    Clin Exp Dermatol; 2007 Jan; 32(1):18-22. PubMed ID: 17305904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practical management of adalimumab].
    Avalos P; Camacho FM
    Actas Dermosifiliogr; 2008 Feb; 99 Suppl 3():25-7. PubMed ID: 18680687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series.
    Bhutani T; Koo J
    J Dermatolog Treat; 2011 Apr; 22(2):75-8. PubMed ID: 20524874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: results in a single community-based hospital.
    Noda S; Mizuno K; Adachi M
    J Dermatol; 2012 Mar; 39(3):265-8. PubMed ID: 22126280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab in the management of palmoplantar psoriasis.
    Ghate JV; Alspaugh CD
    Dermatol Online J; 2009 Jul; 15(7):15. PubMed ID: 19903443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial.
    Leonardi C; Langley RG; Papp K; Tyring SK; Wasel N; Vender R; Unnebrink K; Gupta SR; Valdecantos WC; Bagel J
    Arch Dermatol; 2011 Apr; 147(4):429-36. PubMed ID: 21173304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misunderstandings.
    Feldman SR
    J Dermatolog Treat; 2007; 18(1):4. PubMed ID: 17365258
    [No Abstract]   [Full Text] [Related]  

  • 19. Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.
    Lecluse LL; Driessen RJ; Spuls PI; de Jong EM; Stapel SO; van Doorn MB; Bos JD; Wolbink GJ
    Arch Dermatol; 2010 Feb; 146(2):127-32. PubMed ID: 20157022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of adalimumab in plaque psoriasis: experience on 28 patients.
    Ardigò M; Giuliani A; de Felice C; Mastroianni A; Berardesca E
    J Drugs Dermatol; 2008 Oct; 7(10):935-9. PubMed ID: 19112756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.